Novartis is trading 3.04% up now at $146.74, alongside a healthcare-sector rally. - Healthcare was up 1.64% during regular trading; supplied context attributes strength to UnitedHealth’s earnings beat and improved outlook. - Broader U.S. indices are lower, making sector sentiment the more relevant market context. - No clearly verified Novartis-specific announcement explains the gain. Bank of America maintained its Buy rating and CHF 150 target, but the report does not link it to today’s move.